Swiss Biotech Day 2022 in Basel: Simply great!
May 9, 2022
May 2022- CROss Alliance® is very satisfied for the high interest on CROSS Research […]
Read more
News Archive
CROss Alliance® 2022 calendar has arrived!
Jan 28, 2022
January 2022 – Every end of the year, since 2008, CROss Alliance® develops and […]
Read more
CROss Alliance® becomes a Swiss Biotech Association (SBA) member
Jan 11, 2022
January 2022 – CROss Alliance® is delighted to announce to have joined the Swiss […]
Read more
Clinical phase completion of phase I trial with MAD0004J08 monoclonal antibody against SARS-CoV-2
Dec 20, 2021
December 2021 – CROss Alliance® is glad to announce the completion of the clinical […]
Read more
GIQAR 2021 – The effect of Covid-19 pandemic on Quality
Nov 11, 2021
October 2021 – CROss Alliance QA Unit attended the XXIX GIQAR meeting, sponsoring the […]
Read more
CROss Alliance® successful outcome of Swissmedic GCP System Inspection
Jul 27, 2021
July 2021 – As required by Federal Laws, CROSS activities are periodically subjected to […]
Read more
Accelera and CROSS: an integrated solution for Pre-clinical to Clinical transition
May 17, 2021
May 2021 – The relationship between Accelera and CROss Alliance® started a decade ago […]
Read more
CROSS Research participation in phase 1 study with monoclonal antibody against SARS-COV2
Mar 9, 2021
March 2021 – CROss Alliance® is excited to share the news that on March […]
Read more
Participation of CROss Alliance® in the Zurich Life Science Day 2021
Feb 11, 2021
February 2021 – On the 4th of February, Ursula Herranz, Business Development Unit Head […]
Read more
Covid-19 – Phase I unit re-open
Jun 23, 2020
June 2020 – We are relieved to announce that CROSS Research Phase I Unit […]
Read more